Thanks Mike, it seems that the UK really is publishing what happens about 10 days after the period they're reporting on, it covers a two week period, so it could be roughly 25 days after the actual approval. I would think we'd get a new update shortly, but it will not be current, it will be for the last half of March.
I think it's quite certain the company can disclose action from the regulator, and legally must do so withing a short period of time. I believe the FDA allows 4 days, I'm uncertain of UK requirements. Of course as we learned in the Martha Stewart case, anyone caught acting on the information prior to an official announcement could be charged with insider trading.
I would hope that the company has a well planned program for releasing the information once they know, but it could very well differ depending on when they learn of the decision. In a decision made early in a week, I'd hope they issue and act ASAP, on the other hand, if it's Thursday or later that they get an approval, if allowed an announcement before the bell on Monday, or even an announcement on Saturday or Sunday with a webcast to discuss what's happening would be great for a well organized release of the approval.
Let's see what happens with the next UK release, but I wouldn't expect anything before May given the delay in the data that's reported.
Gary
News 
Market Data 
Discover 
